x

Member Login

Dr. Harminder Singh, MD MPH, Member at Large

Dr. Harminder Singh received his MBBS and MD from All India Institute of Medical Sciences and Masters of Public Health from the University of Manitoba. He received training in gastroenterology, IBD, gastrointestinal oncology and health outcomes research at University of Manitoba. He is currently an Associate Professor of Medicine, Dept. of Internal Medicine and Community Health Sciences, College of Medicine, Faculty of Health Sciences, University of Manitoba. He is a former member of the Canadian Task Force on Preventive Health Care, an organization developing and disseminating clinical practice guidelines for primary care. He is a clinician scientist, epidemiologist and practicing gastroenterologist.

Dr Singh is a member of the Canadian Gastro-Intestinal Epidemiology Consortium (CanGIEC), and a co-author on the Steering Committee of the 2018 Burden of IBD Report for Crohn’s and Colitis Canada (Journal of the Canadian Association of Gastroenterology 2019). He has expertise in using administrative health care datasets to answer a variety of questions, including assessment of outcomes among individuals with inflammatory bowel disease.

Dr. Singh’s research interests have been varied and include clinical epidemiology, pharmaco-epidemiology and health services research. Dr. Singh has lead studies on epidemiology and prevention of colorectal cancer. He has lead studies assessing health care outcomes among individuals with IBD, including skin cancers, cervical cancer precursors, colorectal cancer, screening for cancers, risk of clostridium difficile infections, educational outcomes among those with IBD and care of elderly with IBD. He has lead knowledge translation studies to improve processes around colonoscopy, an essential test to diagnosis and manage those with IBD.